Black Bird Biotech (Black Bird Biotech) FCF Margin % : -125.00% (As of Sep. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Black Bird Biotech FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Black Bird Biotech's Free Cash Flow for the three months ended in Sep. 2023 was $-0.01 Mil. Black Bird Biotech's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, Black Bird Biotech's FCF Margin % for the quarter that ended in Sep. 2023 was -125.00%.

As of today, Black Bird Biotech's current FCF Yield % is -130.17%.

The historical rank and industry rank for Black Bird Biotech's FCF Margin % or its related term are showing as below:

BBBT' s FCF Margin % Range Over the Past 10 Years
Min: -1244.58 Med: -1067.24 Max: -647.22
Current: -647.22

During the past 13 years, the highest FCF Margin % of Black Bird Biotech was -647.22%. The lowest was -1244.58%. And the median was -1067.24%.

BBBT's FCF Margin % is ranked worse than
95.32% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.68 vs BBBT: -647.22

Black Bird Biotech FCF Margin % Historical Data

The historical data trend for Black Bird Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Black Bird Biotech FCF Margin % Chart

Black Bird Biotech Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

-1,067.24

-959.62

-1,244.58

Black Bird Biotech Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
FCF Margin %	Get a 7-Day Free Trial															-480.77	-950.00	-1,414.29	-115.38	-125.00

Competitive Comparison of Black Bird Biotech's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Black Bird Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Black Bird Biotech's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Black Bird Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Black Bird Biotech's FCF Margin % falls into.

Black Bird Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Black Bird Biotech's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-1.033	/	0.083
	=	-1,244.58 %

Black Bird Biotech's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	-0.005	/	0.004
	=	-125.00 %

Black Bird Biotech FCF Margin % Related Terms

Thank you for viewing the detailed overview of Black Bird Biotech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Black Bird Biotech (Black Bird Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Black Bird Biotech Inc (OTCPK:BBBT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

11961 Hilltop Road, Suite 22, Argyle, TX, USA, 76226

Website

https://www.blackbirdpotentials.com

Black Bird Biotech Inc is a licensed grower of industrial hemp under the Montana Hemp Pilot Program. In addition, it is the distributor in the U. S. and Canada for MiteXstream, an EPA-registered plant-based biopesticide effective in the eradication of spider mites, a pest that destroys crops, especially cannabis, hops, coffee, and house plants, as well as molds and mildew. Its products include MiteXstream Biopesticide, Grizzly Creek Naturals, and Black Bird American Hemp.

Executives

Jeffrey A Collins	director, 10 percent owner, officer: President	302 WASHINGTON ST., #513, SAN DIEGO CA 92103
Robert Edward Shea	director, 10 percent owner, officer: President, CEO, CFO, CAO	40 WARREN STREET, 3RD FLOOR, CHARLESTOWN MA 02129
John James Sutherland	director, 10 percent owner, officer: President, CEO, CFO & CAO	C/O SUITE 810 - 675 WEST HASTINGS STREET, VANCOUVER A1 V6B 1N2